Characteristics of patients who received the hepatitis A vaccine before and after implementation of the best practice advisory (BPA)
| Characteristics | Pre intervention (before BPA) | Intervention (after BPA) | |||
| Hepatitis A vaccine | BPA trigger | Hepatitis A vaccine | |||
| Orders | Vaccinated | Orders | Vaccinated | ||
| n | 49 | 32 | 13 429 | 2494 | 1205 |
| Age (years) | |||||
| 18–30 | 10 (20.4%) | 9 (28.1%) | 3192 (23.8%) | 572 (22.9%) | 256 (21.2%) |
| 31–40 | 11 (22.5%) | 7 (21.9%) | 2512 (18.7%) | 476 (19.1%) | 245 (20.3%) |
| 41–50 | 6 (12.2%) | 4 (12.5%) | 2069 (15.4%) | 417 (16.7%) | 212 (17.6%) |
| 51–60 | 11 (22.5%) | 5 (15.6%) | 2484 (18.5%) | 489 (19.6%) | 256 (21.2%) |
| 61–70 | 7 (14.3%) | 5 (15.6%) | 1902 (14.2%) | 338 (13.6%) | 159 (13.2%) |
| >70 | 4 (8.2%) | 2 (6.3%) | 1270 (9.5%) | 202 (8.1%) | 77 (6.4%) |
| Sex | |||||
| Female | 26 (53.1%) | 18 (56.3%) | 5993 (44.6%) | 1031 (41.3%) | 471 (39.1%) |
| Male | 23 (46.9%) | 14 (43.7%) | 7436 (55.4%) | 1463 (58.7%) | 734 (60.9%) |
| Race | |||||
| White/Caucasian | 32 (65.3%) | 19 (59.4%) | 8233 (61.3%) | 1543 (61.9%) | 751 (62.3%) |
| Black/African American | 16 (32.7%) | 12 (37.5%) | 4775 (35.6%) | 879 (35.2%) | 418 (34.7%) |
| Other | 1 (2.0%) | 1 (3.1%) | 421 (3.1%) | 72 (2.9%) | 36 (3.0%) |